Concepedia

Publication | Open Access

Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD

43

Citations

44

References

2018

Year

Abstract

CD8<sup>+</sup> Foxp3<sup>+</sup> T cells (Tregs) are a potent regulatory population whose functional and ontological similarities to CD4<sup>+</sup> Fox3<sup>+</sup> T cells have not been well delineated. Using an experimental model of graft-versus-host disease (GVHD), we observed that CD8<sup>+</sup> Tregs were significantly less potent than CD4<sup>+</sup> Tregs for the suppression of GVHD. To define the mechanistic basis for this observation, we examined the T-cell repertoire and the transcriptional profile of in vivo-derived CD4<sup>+</sup> and CD8<sup>+</sup> Tregs that emerged early during this disease. Polyclonal and alloantigen-induced CD8<sup>+</sup> Tregs had repertoire diversity that was similar to that of conventional CD8<sup>+</sup> T cells, indicating that a restricted repertoire was not the proximate cause of decreased suppression. Transcriptional profiling revealed that CD8<sup>+</sup> Tregs possessed a canonical Treg transcriptional signature that was similar to that observed in CD4<sup>+</sup> Tregs, yet distinct from conventional CD8<sup>+</sup> T cells. Pathway analysis, however, demonstrated that CD8<sup>+</sup> Tregs had differential gene expression in pathways involved in cell death and survival. This was further confirmed by detailed mRNA sequence analysis and protein expression studies, which demonstrated that CD8<sup>+</sup> Tregs had increased expression of Bim and reduced expression of Mcl-1. Transplantation with CD8<sup>+</sup> Foxp3<sup>+</sup> Bim<sup>-/-</sup> Tregs resulted in prolonged Treg survival and reduced GVHD lethality compared with wild-type CD8<sup>+</sup> Tregs, providing functional confirmation that increased expression of Bim was responsible for reduced in vivo efficacy. Thus, Bim regulates the survival and suppressive capability of CD8<sup>+</sup> Tregs, which may have implications for their use in regulatory T-cell therapy.

References

YearCitations

Page 1